Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures
- PMID: 20691423
- PMCID: PMC2967587
- DOI: 10.1016/j.ajo.2010.05.030
Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures
Abstract
Purpose: To assess vision-specific quality of life (QOL), based on abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire (NEI-VFQ), in a cohort of United States women who participated in the Study of Osteoporotic Fractures.
Design: Prospective, observational cohort study.
Methods: Age-related macular degeneration (AMD) status, based on a 3-level classification (no AMD, early AMD, late AMD), and vision-specific QOL, based on abbreviated NEI-VFQ surveys, were calculated for 1674 women enrolled in the Study of Osteoporotic Fractures at 4 centers within the United States who had gradable fundus photographs at both the 10-year and 15-year follow-up visits. The associations among 5-year changes in NEI-VFQ composite scores, change in AMD status, and distance visual acuity were examined.
Results: Compared with study participants without AMD at both visits, study participants with late AMD at both visits and those who progressed from early AMD to late AMD demonstrated the greatest declines in adjusted NEI-VFQ composite scores, up to a mean decrease of 16.2 from a scale of 100. Visual acuity declines also were most prominent for patients with late AMD at both visits and for those who progressed from early AMD to late AMD. Change in visual acuity was found to correlate significantly with change in vision-specific QOL.
Conclusions: The abbreviated NEI-VFQ surveys provide reliable assessments of vision-specific QOL in AMD patients. The decline in vision-specific QOL associated with the progression of AMD is clinically meaningful.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures.Am J Ophthalmol. 2010 Feb;149(2):330-40. doi: 10.1016/j.ajo.2009.09.008. Am J Ophthalmol. 2010. PMID: 20103058 Free PMC article.
-
Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.Arch Ophthalmol. 2005 Sep;123(9):1207-14. doi: 10.1001/archopht.123.9.1207. Arch Ophthalmol. 2005. PMID: 16157800 Free PMC article.
-
Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.Ophthalmology. 2005 Jan;112(1):144-51. doi: 10.1016/j.ophtha.2004.06.035. Ophthalmology. 2005. PMID: 15629835
-
A Review of Studies of the Association of Vision-Related Quality of Life with Measures of Visual Function and Structure in Patients with Glaucoma in the United States.Ophthalmic Epidemiol. 2021 Jun;28(3):265-276. doi: 10.1080/09286586.2020.1863992. Epub 2021 Feb 3. Ophthalmic Epidemiol. 2021. PMID: 33530788 Free PMC article. Review.
-
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review.Clin Ther. 2021 Oct;43(10):1792-1818. doi: 10.1016/j.clinthera.2021.08.011. Epub 2021 Sep 20. Clin Ther. 2021. PMID: 34548176 Review.
Cited by
-
Medicare costs for neovascular age-related macular degeneration, 1994-2007.Am J Ophthalmol. 2011 Dec;152(6):1014-20. doi: 10.1016/j.ajo.2011.05.008. Epub 2011 Aug 16. Am J Ophthalmol. 2011. PMID: 21843875 Free PMC article.
-
Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology.J Glaucoma. 2021 May 1;30(5):388-394. doi: 10.1097/IJG.0000000000001795. J Glaucoma. 2021. PMID: 33492894 Free PMC article. Clinical Trial.
-
Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT).Graefes Arch Clin Exp Ophthalmol. 2025 Jan 15. doi: 10.1007/s00417-024-06727-z. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39812799
-
Enrichment of Bruch's Membrane from Human Donor Eyes.J Vis Exp. 2015 Nov 15;(105):53382. doi: 10.3791/53382. J Vis Exp. 2015. PMID: 26650722 Free PMC article.
-
Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.Int Ophthalmol. 2025 Jul 21;45(1):304. doi: 10.1007/s10792-025-03679-z. Int Ophthalmol. 2025. PMID: 40690044
References
-
- The Eye Disease Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485. - PubMed
-
- Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study I. Outline and major prevalence. Am J Epidemiol. 1977;106:17–32. - PubMed
-
- Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Eng J Med. 1991;325:1412–1417. - PubMed
-
- Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571–573. - PubMed
-
- Health, United States. Hyattsville, MD: National Center for Health Statistics Public Health Service; 1990.
Publication types
MeSH terms
Grants and funding
- 2 R01 AG005394-22A1/AG/NIA NIH HHS/United States
- R01 AR035583/AR/NIAMS NIH HHS/United States
- AR35582/AR/NIAMS NIH HHS/United States
- R01 AR035584/AR/NIAMS NIH HHS/United States
- R01 AG027576/AG/NIA NIH HHS/United States
- 2 R01 AG027574-22A1/AG/NIA NIH HHS/United States
- U10 EY013626/EY/NEI NIH HHS/United States
- R01 AG005407/AG/NIA NIH HHS/United States
- EY013626-03/EY/NEI NIH HHS/United States
- R01 AR035582/AR/NIAMS NIH HHS/United States
- R01 AG005394/AG/NIA NIH HHS/United States
- AR35584/AR/NIAMS NIH HHS/United States
- R01 AG027574/AG/NIA NIH HHS/United States
- R01 AG027576-22/AG/NIA NIH HHS/United States
- AR35583/AR/NIAMS NIH HHS/United States